Sponsored By

Originally developed for Bard’s own branded stents, ePTFE encapsulation is suited for transcatheter heart valves and other medical devices that benefit from its thin, high-strength, microporous and biocompatible properties.

PlasticsToday Staff

February 3, 2017

1 Min Read
Bard now offers ePTFE encapsulation services to cardiovascular device manufacturers

Bard Peripheral Vascular OEM Products (Tempe, AZ), a division of C.R. Bard, has announced that it is making available its expanded polytetrafluoroethylene (ePTFE) encapsulation services to cardiovascular device manufacturers. Originally developed for Bard’s own branded stents, ePTFE encapsulation is suited for transcatheter heart valves and other medical devices that benefit from its thin, high-strength, microporous and biocompatible properties.

Celebrating its 40th anniversary this month, Bard PV OEM provides, along with its textile and ePTFE offerings, a comprehensive range of standard size PTA and PTCA angioplasty balloon catheters on an OEM basis. These catheters can be used for typical balloon angioplasty and stent delivery. Bard ClearStream Technologies has the ability to design, develop and manufacture angioplasty balloon catheters specifically for OEM and medical device customers.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like